Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TPST files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTempest Therapeutics reports Q1 2026 financial results
Filed May 14, 2026 · Period ending May 14, 2026 · ~1 min read
Key Changes
-
medium
Company announced financial results for the quarter ended March 31, 2026, along with business highlights. Specific figures are in the attached press release not included in the 8-K filing text.
Item 2.02 verify on EDGAR → -
low
This is a routine quarterly earnings disclosure filed via 8-K with press release attachment. No unusual events or material business changes disclosed in the filing body.
8-K: Earnings view on EDGAR →
Summary
Tempest Therapeutics filed its routine quarterly earnings 8-K announcing first quarter 2026 financial results for the period ending March 31, 2026. The filing itself contains minimal detail, with the actual financial figures and business updates contained in an attached press release (Exhibit 99.1) that is not reproduced in the 8-K body text. For retail investors, this is a standard quarterly disclosure with no red flags or unusual elements.
The filing provides no insight into the actual financial performance or business developments without access to the press release. Investors should review the full press release on the company's investor relations website or SEC EDGAR to understand Q1 performance, cash position, and any pipeline updates. Watch for the upcoming 10-Q filing, which will provide complete financial statements and management discussion of quarterly results.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 14, 2026, Tempest Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026 and other business highlights.
The company disclosed its financial results for the first quarter of 2026 ending March 31, 2026, along with other business highlights. The actual financial figures and business updates are contained in the attached press release (Exhibit 99.1), which is not included in this 8-K body text.
Event · Item 9.01 — Financial Statements and Exhibits
Item 9.01 — Financial Statements and Exhibits filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
99.1 Press release dated May 14, 2026
The company attached a press release dated May 14, 2026 as Exhibit 99.1. The 8-K body does not describe the content of the press release, so the nature of the disclosure cannot be determined from this filing alone.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 25, 2026 · How we verify